The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%

Thursday, February 13, 2020 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Feb. 12, 2020 /PRNewswire/ --

The global transplant diagnostics market is projected to grow at a CAGR of 7.2% during the forecast period.

Read the full report: https://www.reportlinker.com/p04606005/?utm_source=PRN

The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. The demand for transplant diagnostic products is expected to grow due to technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities. The transplant diagnostics market is segmented on product, technology, application, transplant type, end user, and region.The independent reference laboratories segment accounted for the largest share of the transplant diagnostics market, by end user, in 2019.Based on end user, the transplant diagnostics market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the transplant diagnostics market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019.The transplant diagnostics market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.North America accounted for the largest share of the transplant diagnostics market in 2019.North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.Breakdown of supply-side primary interviews:• By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)• By Designation: C-level (10%), Director-level (14%), and Others (76%)• By Region: North America (40%), Europe (32%), APAC (20%), and RoW (8%)Some of the prominent players in the transplant diagnostics market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), bioMérieux (France), Becton, Dickinson and Company (US), and Omixon (Hungary).Research CoverageThis report studies the transplant diagnostics market based on product, technology, application, transplant type, end user, and region.It studies major factors (such as drivers and restraints) affecting market growth.The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market.The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.Key Benefits of Buying the ReportThis report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views.It also analyzes the competitive landscape; emerging segments of the transplant diagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities.The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.Read the full report: https://www.reportlinker.com/p04606005/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-transplant-diagnostics-market-is-expected-to-reach-usd-5-5-billion-by-2025-from-usd-3-6-billion-in-2019--at-a-cagr-of-7-2-301003907.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store